Conduction System Pacing vs Right Ventricular Pacing in Preserved or Mildly Reduced Ejection Fraction: A
Abdalhakim Shubietah1, Mohamed Saad Rakab2, Elsayed Balbaa3
1Department of Medicine, Advocate Illinois Masonic Medical Center, Chicago, Illinois, USA.
The Canadian Journal of Cardiology
|April 23, 2026
Summary
Conduction system pacing (CSP) significantly lowers pacing-induced cardiomyopathy and heart failure hospitalizations compared to right ventricular pacing (RVP) in patients with preserved or mildly reduced ejection fraction. While CSP shows benefits, it involves longer procedure times.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Observational studies on conduction system pacing (CSP) versus right ventricular pacing (RVP) show mixed results regarding patient outcomes.
- Patients with preserved or mildly reduced left ventricular ejection fraction (LVEF) requiring permanent pacing are the focus of this comparison.
Purpose of the Study:
- To compare the efficacy and safety of CSP versus RVP in randomized controlled trials (RCTs).
- To evaluate the impact of CSP on pacing-induced cardiomyopathy (PICM), heart failure hospitalizations (HFH), and left ventricular function.
Main Methods:
- A meta-analysis of RCTs comparing CSP modalities with RVP was conducted.
- Databases were searched through February 24, 2026, with outcomes pooled using random-effects models.
Main Results:
- CSP significantly reduced PICM (4.6% vs 16.2%) and HFH (3.3% vs 9.1%) compared to RVP.
- CSP improved LVEF and shortened paced QRS duration but had lower pacing success rates and longer procedural/fluoroscopy times.
Conclusions:
- CSP is a viable preventive strategy for patients with preserved or mildly reduced LVEF anticipated to require substantial ventricular pacing.
- CSP demonstrates superior outcomes in reducing PICM and HFH, alongside better preservation of LV function compared to RVP.
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
783
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
783
01:20Conduction System of the Heart
6.0K
The cardiac conduction system produces and transmits electrical impulses that prompt myocardial contraction, ensuring efficient heart function. This intricate system ensures that the heart beats in a coordinated and efficient manner, beginning with the atria and then the ventricles. The conduction system optimizes cardiac output by maintaining this precise sequence, which is crucial for adequate blood circulation.
This system relies on the unique properties of nodal and Purkinje cells:...
This system relies on the unique properties of nodal and Purkinje cells:...
6.0K
01:19Conduction System of the Heart
12.9K
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
12.9K
01:17Pathophysiology of Heart Failure
4.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.6K
01:29Heart Failure II: Pathophysiology
1.6K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.6K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
801
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801